RNA-based screening for preterm preeclampsia reduces costs in pregnancies of advanced maternal age
SMFM 2026 POSTER SESSION
Presented by
Carrie Haverty, MS, CGC,
VP of Medical Affairs
Poster session 3
Thursday, February 12, 2026
10:30 AM - 12:00 PM
Download available once the session begins.
RNA-based preeclampsia prediction risk test Encompass™ enables more effective preventive intervention than current guidelines, saving $56 million per 10,000 tested.
